Advocacy & Legislative NHF & HFA Respond to New Blue Cross Blue Shield of Tennessee FormulariesJan 20, 2023 Industry New FIX Chromogenic Assay Launched by Precision BioLogic Jan 18, 2023 Industry Biomarin Provides Hemophilia A Clinical Development Program UpdatesJan 10, 2023 Industry Takeda Announces Trial Results on Investigational Therapy for Ultra Rare Blood…Jan 10, 2023 Press Releases NHF Announces 2023 Winter/Spring Wednesday Webinar ScheduleJan 5, 2023 Industry Pfizer Announces Trial Updates for Investigational Hemophilia Gene TherapyJan 4, 2023 Press Releases NHF Assumes Leadership of the American Plasma Users CoalitionJan 3, 2023 NBDF & Community NHF's Own Your Path program begins recruitmentDec 21, 2022 Industry Spark Announces SPK-8011 Updates at ASHDec 15, 2022 Press Releases National Hemophilia Foundation Set to Celebrate 75 Years in 2023 Dec 13, 2022 Medical First Hemophilia B Gene Therapy Approved by FDANov 23, 2022 Press Releases NHF kicks off the season of giving with Giving ShoesdayNov 22, 2022 Medical New Document to Help Residential Substance Use Disorder…Nov 14, 2022 Press Releases National Hemophilia Foundation Celebrates 50 Years of the Judith Graham Pool…Nov 14, 2022 NBDF & Community Continued Conversation on the State of Access to Women’s Health CareNov 9, 2022 Pagination First page Previous page … Page 22 Page 23 Page 24 Page 25 Current page 26 Page 27 Page 28 Page 29 Page 30 … Next page Last page